AT Bancorp’s Edwards Lifesciences EW Stock Holding History

AT Bancorp’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.01M	Sell	31,560 -23,724	-43%	-$1.35M	0.24%	48
2018 Q4	$2.82M	Sell	55,284 -4,713	-8%	-$238K	0.37%	27
2018 Q3	$3.48M	Sell	59,997 -1,881	-3%	-$92K	0.38%	32
2018 Q2	$3M	Sell	61,878 -690	-1%	-$32.2K	0.33%	38
2018 Q1	$2.91M	Sell	62,568 -26,688	-30%	-$1.16M	0.31%	38
2017 Q4	$3.35M	Buy	89,256 +11,655	+15%	+$428K	0.36%	31
2017 Q3	$2.83M	Buy	77,601 +5,322	+7%	+$203K	0.32%	34
2017 Q2	$2.85M	Sell	72,279 -33,099	-31%	-$1.21M	0.33%	32
2017 Q1	$3.3M	Buy	105,378 +31,851	+43%	+$997K	0.42%	43
2016 Q4	$2.3M	Buy	+73,527	New	+$2.38M	0.31%	58

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

AT Bancorp's EW Position: Q1 2019 in Review

AT Bancorp reduced its Edwards Lifesciences (EW) stake by 43% in Q1 2019, selling an estimated $1.35M and leaving 31,560 shares worth $2.01M. The position accounts for 0.24% of the portfolio, ranked #48.

AT Bancorp first reported a position in EW in Q4 2016 and has held it in 10 quarters since. The position peaked at $3.48M in Q3 2018. 922 funds tracked by Wall St. Rank hold EW as of Q1 2019.

AT Bancorp held 31,560 shares of Edwards Lifesciences worth $2.01M as of Q1 2019.
AT Bancorp sold 23,724 Edwards Lifesciences shares in Q1 2019, an estimated $1.35M.
Edwards Lifesciences made up 0.24% of AT Bancorp's portfolio in Q1 2019, its #48 holding.
AT Bancorp first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 10 quarters since.
AT Bancorp's Edwards Lifesciences position peaked at $3.48M in Q3 2018.
922 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on AT Bancorp's 13F filing for Q1 2019, filed 13 May 2019.